Compare GNE & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNE | MASS |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.1M | 326.0M |
| IPO Year | 2011 | 2020 |
| Metric | GNE | MASS |
|---|---|---|
| Price | $14.55 | $8.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $16.00 | $12.00 |
| AVG Volume (30 Days) | 75.2K | ★ 297.0K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | 95.65 | ★ 125.47 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $425,202,000.00 | $56,197,000.00 |
| Revenue This Year | $17.49 | $19.44 |
| Revenue Next Year | $7.07 | $18.63 |
| P/E Ratio | $128.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.69 | $5.03 |
| 52 Week High | $28.08 | $9.34 |
| Indicator | GNE | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 59.90 |
| Support Level | $13.44 | $7.57 |
| Resistance Level | $14.75 | $9.20 |
| Average True Range (ATR) | 0.41 | 0.45 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 77.14 | 74.25 |
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.